Get started

Financials · GDRX

GoodRx Holdings Inc. (GDRX) financials

For the twelve months ended Jun 30, 2026, GoodRx Holdings Inc. reported $785.23M of revenue and $16.25M of net income.

Revenue, TTM
$785.23M
Revenue growth, YoY
-1.8%
Net income, TTM
$16.25M
Net income growth, YoY
-53.0%
Net margin
2.1%
Free cash flow, TTM
$197.09M
EPS, diluted, TTM
$0.04
Cash
$296.11M
Total debt
$486.59M
P/E
73.69
P/S
1.52
Market cap
$1.20B
Annual revenue$796.85M
FY2018FY2025
Annual net income$30.44M
FY2018FY2025
Annual free cash flow$164.38M
FY2018FY2025

GDRX revenue and earnings growth

GDRX revenueQ2 2026$200.41M

Quarter YoY
-1.3%
QoQ
+3.3%
FY YoY
+0.6%
5Y CAGR
+7.7%

GDRX revenue was $200.41M in fiscal Q2 2026 (ended Jun 30, 2026), down 1.3% from a year earlier and up 3.3% from the prior quarter. For the full fiscal 2025 it was $796.85M, up 0.6% from fiscal 2024. Compound annual growth was +7.7% over 5 years. It rose in 6 of the last 7 fiscal years. Fiscal 2025 is the highest of the 8 fiscal years on file.

GDRX net incomeQ2 2026$8.54M

Quarter YoY
-33.5%
QoQ
+630.2%
FY YoY
+85.7%

GDRX net income was $8.54M in fiscal Q2 2026 (ended Jun 30, 2026), down 33.5% from a year earlier and up 630.2% from the prior quarter. For the full fiscal 2025 it was $30.44M, up 85.7% from fiscal 2024.

GDRX EPSQ2 2026$0.02

Quarter YoY
-50.0%
FY YoY
+125.0%

GDRX diluted EPS was $0.02 in fiscal Q2 2026 (ended Jun 30, 2026), down 50.0% from a year earlier. For the full fiscal 2025 it was $0.09, up 125.0% from fiscal 2024.

GDRX free cash flowQ2 2026$80.47M

Quarter YoY
+63.6%
QoQ
+651.9%
FY YoY
-10.0%
5Y CAGR
+8.2%

GDRX free cash flow was $80.47M in fiscal Q2 2026 (ended Jun 30, 2026), up 63.6% from a year earlier and up 651.9% from the prior quarter. For the full fiscal 2025 it was $164.38M, down 10.0% from fiscal 2024. Compound annual growth was +8.2% over 5 years. It rose in 4 of the last 7 fiscal years.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
Revenue$796.85M$792.32M$750.26M$766.55M$745.42M$550.70M$388.22M$249.52M
Research and development$121.03M$123.75M$135.84M$143.14M$125.86M$61.82M$29.30M$43.89M
Selling, general and admin$113.96M$117.86M$125.52M$144.79M$154.69M$461.45M$14.69M$8.36M
Operating income$87.49M$65.85M-$27.01M$1.74M$13.41M-$275.72M$139.68M$77.25M
Interest expense$42.60M$52.92M$56.73M$34.24M----
Pre-tax income$56.54M$31.46M-$55.57M-$23.23M-$10.18M-$303.45M$82.98M$52.35M
Income tax$26.10M$15.07M-$46.70M$9.60M$15.08M-$9.83M$16.93M$8.55M
Net income$30.44M$16.39M-$8.87M-$32.83M-$25.25M-$293.62M$66.05M$43.79M
EPS, basic$0.09$0.04-$0.02-$0.08-$0.06-$1.07$0.19$0.12
EPS, diluted$0.09$0.04-$0.02-$0.08-$0.06-$1.07$0.18$0.12
Diluted shares357.0M392.2M410.3M412.9M410.0M274.7M231.2M118.3M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
Cash and equivalents$261.82M$448.35M$672.30M$757.16M$941.11M$968.69M$26.05M$34.60M
Receivables$235.75M$145.93M$143.61M$117.14M$118.08M$68.73M$48.13M-
Current assets$643.10M$659.25M$872.79M$919.69M$1.09B$1.09B$86.58M-
Goodwill$430.33M$410.77M$410.77M$412.12M$329.70M$261.12M$236.22M$220.42M
Total assets$1.40B$1.39B$1.59B$1.60B$1.61B$1.47B$386.80M-
Current liabilities$246.00M$123.90M$122.56M$76.32M$81.11M$59.55M$33.37M-
Short-term debt$5.00M$5.00M$8.79M$7.03M$7.03M$7.03M$7.03M-
Long-term debt$483.26M$486.71M$647.70M$651.80M$655.86M$659.89M$663.89M-
Total debt$488.26M$491.71M$656.49M$658.83M$662.89M$666.92M$670.92M-
Total liabilities$787.80M$663.41M$826.84M$789.80M$775.95M$758.75M$737.37M-
Shareholders' equity$616.26M$724.66M$761.96M$814.83M$831.68M$711.36M-$1.09B-$1.16B

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
Operating cash flow$167.90M$183.89M$138.29M$146.78M$178.78M$131.34M$83.29M$45.25M
Capital expenditures$3.52M$1.24M$1.04M$3.97M$4.57M$20.55M$1.43M$804.0K
Free cash flow$164.38M$182.65M$137.25M$142.81M$174.21M$110.79M$81.86M$44.45M
Investing cash flow-$119.96M-$70.35M-$55.77M-$210.50M-$178.73M-$91.62M-$37.05M-$3.46M
Financing cash flow-$234.47M-$337.50M-$167.40M-$120.23M-$30.53M$905.82M-$54.78M-$24.73M
Dividends paid-------$1.35B
Share repurchases$216.37M$158.84M$103.97M$101.72M$0$0--
Stock-based compensation$76.63M$99.03M$104.82M$120.23M$160.46M$397.29M$3.75M$1.76M
Depreciation and amortization$85.22M$69.54M$107.67M$54.18M$34.54M$18.43M$13.57M$9.81M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
Revenue growth, YoY0.6%5.6%-2.1%2.8%35.4%41.9%55.6%-
Net income growth, YoY85.7%-----50.8%-
EPS growth, YoY125.0%-------
Operating margin11.0%8.3%-3.6%0.2%1.8%-50.1%36.0%31.0%
Net margin3.8%2.1%-1.2%-4.3%-3.4%-53.3%17.0%17.6%
Free cash flow margin20.6%23.1%18.3%18.6%23.4%20.1%21.1%17.8%
Return on equity4.9%2.3%-1.2%-4.0%-3.0%-41.3%--
Return on assets2.2%1.2%-0.6%-2.0%-1.6%-20.0%17.1%-
Current ratio2.615.327.1212.0513.4218.242.59-
Debt to equity0.790.680.860.810.800.94--

Source: XBRL data GoodRx Holdings Inc. files with the SEC, latest filing dated Aug 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

GDRX peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
GDRX$785.23M-1.8%$16.25M2.1%$1.20B
ADP$22.26B+6.5%$4.53B20.3%$119.75B
INFY$20.16B+4.6%$3.31B16.4%$50.70B
WDAY$10.15B+13.3%$1.25B12.3%$46.49B
ZS$3.35B+25.4%-$63.18M-1.9%$32.23B
CTSH$21.89B+5.0%$2.57B11.8%$28.93B
VRSN$1.73B+6.5%$849.80M49.1%$27.69B
VRSK$3.18B+4.9%$879.20M27.7%$26.63B
IOT$1.85B+29.5%$90.55M4.9%$24.00B

GDRX FAQ

8 questions
  • What is GDRX revenue?
    GoodRx Holdings Inc. (GDRX) reported $785.23M of revenue for the twelve months ended Jun 30, 2026. That is down 1.8% from the year before. Revenue for fiscal 2025 was $796.85M.
  • Is GDRX profitable?
    Yes. GoodRx Holdings Inc. earned $16.25M in net income for the twelve months ended Jun 30, 2026, a net margin of 2.1%.
  • How much cash and debt does GDRX have?
    GoodRx Holdings Inc. reported $296.11M in cash and cash equivalents and $486.59M of debt on its most recent balance sheet in SEC filings.
  • How fast is GDRX revenue growing?
    GoodRx Holdings Inc.'s revenue changed +0.6% in fiscal 2025, to $796.85M. Its compound annual growth rate was +7.7% over 5 years.
  • What is GDRX free cash flow?
    GoodRx Holdings Inc. generated $197.09M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $201.58M less capital expenditures.
  • What is GDRX earnings per share?
    Diluted earnings per share were $0.04 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did GDRX last report financial results?
    The latest statements here come from GoodRx Holdings Inc.'s 10-Q filed on Aug 5, 2026, covering the period ended Jun 30, 2026.
  • Where does this GDRX financial data come from?
    Quantisnow builds these statements from the structured XBRL data GoodRx Holdings Inc. files with the SEC. It is provided for information only and is not investment advice.